15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering InflaRx N.V, 4 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $2.00 to $14.00 (about 7.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $7.40 sits 338% above the current $1.69. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.05 next quarter toward $-0.37 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy120%
Buy360%
Hold120%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to InflaRx N.V.
As of Jul, 4 of 5 firms rate IFRX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IFRX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.05
Range $-0.07 – $-0.04 · 4 analysts · -71% YoY
Next period, 4 analysts expect InflaRx N.V. to earn $-0.05 a share (range $-0.07 – $-0.04), versus $-0.18 a year earlier. Full-year consensus is $-0.30, growing to $-0.37 the year after.
REVENUE · NEXT QUARTER
$3.5K
Range $0 – $21.0K · 4 analysts · -85% YoY
Revenue is expected to reach $3.5K (range $0 – $21.0K), -85.3% year-over-year. Full-year consensus is $10.3K, rising to $13.5K next year.
Top analysts covering InflaRx N.V.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IFRX.
#1
Yatin Suneja
Guggenheim · Rank #28
Buy
$14.00+728.4% to target
Overall win rate
52%
+ Follow
#2
EW
Edward White
HC Wainwright & Co. · Rank #241
Buy
$8.00+373.4% to target
Overall win rate
31%
+ Follow
#3
MK
Matthew Keller
HC Wainwright & Co.
Buy
$8.00+373.4% to target
Coverage
—
+ Follow
#4
Andreas Argyrides
Oppenheimer
Buy
$5.00+195.9% to target
Coverage
—
+ Follow
#5
Steven Seedhouse
Cantor Fitzgerald
Buy
$4.00+136.7% to target
Coverage
—
+ Follow
IFRX stock forecast FAQ
What is IFRX's average 12-month price target?+
The 5 analysts with a live target average $7.40 for InflaRx N.V. over the next 12 months, ranging from a $14.00 high to a $2.00 low.
Is IFRX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for IFRX?+
The Street-high target is $14.00 (Guggenheim), and the Street-low is $2.00 (Leerink Partners). The average of all 5 active targets is $7.40.
How many Wall Street analysts cover IFRX?+
5 analysts have an active rating on InflaRx N.V., and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering IFRX?+
Among analysts who currently cover IFRX, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #28). Their current call is Buy with a $14.00 target.
What is InflaRx N.V.'s projected EPS for next quarter?+
The consensus estimate is $-0.05 per share (range $-0.07 – $-0.04) across 4 analysts. Full-year EPS is projected at $-0.30, rising to $-0.37 the following year.
How much revenue is InflaRx N.V. expected to report next quarter?+
Consensus revenue is $3.5K (range $0 – $21.0K). Full-year revenue is projected at $10.3K, growing to $13.5K next year.
Have analysts been upgrading or downgrading IFRX lately?+
As of Jul, 4 of 5 firms rate IFRX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IFRX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
